<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD06740000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P02751</UniProt_ID>
  <Seq_Length>2386</Seq_Length>
  <Molecule_Weight>262625</Molecule_Weight>
  <KEGG_ID>hsa:2335</KEGG_ID>
  <Orthology_ID>K05717</Orthology_ID>
  <Function_Summary>Fibronectins bind cell surfaces and various compounds including collagen, fibrin, heparin, DNA, and actin. Fibronectins are involved in cell adhesion, cell motility, opsonization, wound healing, and maintenance of cell shape.Anastellin binds fibronectin and induces fibril formation. This fibronectin polymer, named superfibronectin, exhibits enhanced adhesive properties. Both anastellin and superfibronectin inhibit tumor growth, angiogenesis and metastasis. Anastellin activates p38 MAPK and inhibits lysophospholipid signaling.</Function_Summary>
  <Pfam_ID>PF00039:fn1@@PF00040:fn2@@PF00041:fn3</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>CIG</Alias>
      <Alias>Anastellin</Alias>
      <Alias>Ugl-Y2</Alias>
      <Alias>Ugl-Y3</Alias>
      <Alias>Ugl-Y1</Alias>
      <Alias>FN</Alias>
      <Alias>Cold-insoluble globulin</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with collagen, a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).</Detail>
      <Keyword>Collagen binding</Keyword>
      <Ontology_ID>GO:0005518</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha1-4-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.</Detail>
      <Keyword>Heparin binding</Keyword>
      <Ontology_ID>GO:0008201</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>The action of a molecule that contributes to the structural integrity of the extracellular matrix.</Detail>
      <Keyword>Extracellular matrix structural constituent</Keyword>
      <Ontology_ID>GO:0005201</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>2121</Position>
      <Original>Ile</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>1834</Position>
      <Original>Trp</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>1960</Position>
      <Original>Ile</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>1883</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>1467</Position>
      <Original>Ser</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>15</Position>
      <Original>Gln</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>973</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>2170</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>940</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>2380</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>817</Position>
      <Original>Thr</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>1120</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.</Detail>
      <Keyword>Platelet degranulation</Keyword>
      <Ontology_ID>GO:0002576</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>An acute inflammatory response that involves non-antibody proteins whose concentrations in the plasma increase in response to infection or injury of homeothermic animals.</Detail>
      <Keyword>Acute-phase response</Keyword>
      <Ontology_ID>GO:0006953</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.</Detail>
      <Keyword>Cell adhesion</Keyword>
      <Ontology_ID>GO:0007155</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The movement of a leukocyte within or between different tissues and organs of the body.</Detail>
      <Keyword>Leukocyte migration</Keyword>
      <Ontology_ID>GO:0050900</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.</Detail>
      <Keyword>Angiogenesis</Keyword>
      <Ontology_ID>GO:0001525</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the surface configuration of a cell.</Detail>
      <Keyword>Regulation of cell shape</Keyword>
      <Ontology_ID>GO:0008360</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The morphogenetic process that results in flattening of a cell as a consequence of its adhesion to a substrate.</Detail>
      <Keyword>Substrate adhesion-dependent cell spreading</Keyword>
      <Ontology_ID>GO:0034446</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The formation of a covalent cross-link between or within protein chains.</Detail>
      <Keyword>Peptide cross-linking</Keyword>
      <Ontology_ID>GO:0018149</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.</Detail>
      <Keyword>Platelet activation</Keyword>
      <Ontology_ID>GO:0030168</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>2341</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>881</Position>
      <PTM_Type>Sulfotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>904</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>876</Position>
      <PTM_Type>Sulfotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>2384</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>2349</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>32</Position>
      <PTM_Type>Pyrrolidone carboxylic acid</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MLRGPGPGLLLLAVQCLGTAVPSTGASKSKRQAQQMVQPQSPVAVSQSKPGCYDNGKHYQINQQWERTYLGNALVCTCYGGSRGFNCESKPEAEETCFDKYTGNTYRVGDTYERPKDSMIWDCTCIGAGRGRISCTIANRCHEGGQSYKIGDTWRRPHETGGYMLECVCLGNGKGEWTCKPIAEKCFDHAAGTSYVVGETWEKPYQGWMMVDCTCLGEGSGRITCTSRNRCNDQDTRTSYRIGDTWSKKDNRGNLLQCICTGNGRGEWKCERHTSVQTTSSGSGPFTDVRAAVYQPQPHPQPPPYGHCVTDSGVVYSVGMQWLKTQGNKQMLCTCLGNGVSCQETAVTQTYGGNSNGEPCVLPFTYNGRTFYSCTTEGRQDGHLWCSTTSNYEQDQKYSFCTDHTVLVQTRGGNSNGALCHFPFLYNNHNYTDCTSEGRRDNMKWCGTTQNYDADQKFGFCPMAAHEEICTTNEGVMYRIGDQWDKQHDMGHMMRCTCVGNGRGEWTCIAYSQLRDQCIVDDITYNVNDTFHKRHEEGHMLNCTCFGQGRGRWKCDPVDQCQDSETGTFYQIGDSWEKYVHGVRYQCYCYGRGIGEWHCQPLQTYPSSSGPVEVFITETPSQPNSHPIQWNAPQPSHISKYILRWRPKNSVGRWKEATIPGHLNSYTIKGLKPGVVYEGQLISIQQYGHQEVTRFDFTTTSTSTPVTSNTVTGETTPFSPLVATSESVTEITASSFVVSWVSASDTVSGFRVEYELSEEGDEPQYLDLPSTATSVNIPDLLPGRKYIVNVYQISEDGEQSLILSTSQTTAPDAPPDTTVDQVDDTSIVVRWSRPQAPITGYRIVYSPSVEGSSTELNLPETANSVTLSDLQPGVQYNITIYAVEENQESTPVVIQQETTGTPRSDTVPSPRDLQFVEVTDVKVTIMWTPPESAVTGYRVDVIPVNLPGEHGQRLPISRNTFAEVTGLSPGVTYYFKVFAVSHGRESKPLTAQQTTKLDAPTNLQFVNETDSTVLVRWTPPRAQITGYRLTVGLTRRGQPRQYNVGPSVSKYPLRNLQPASEYTVSLVAIKGNQESPKATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPRIGFKLGVRPSQGGEAPREVTSDSGSIVVSGLTPGVEYVYTIQVLRDGQERDAPIVNKVVTPLSPPTNLHLEANPDTGVLTVSWERSTTPDITGYRITTTPTNGQQGNSLEEVVHADQSSCTFDNLSPGLEYNVSVYTVKDDKESVPISDTIIPAVPPPTDLRFTNIGPDTMRVTWAPPPSIDLTNFLVRYSPVKNEEDVAELSISPSDNAVVLTNLLPGTEYVVSVSSVYEQHESTPLRGRQKTGLDSPTGIDFSDITANSFTVHWIAPRATITGYRIRHHPEHFSGRPREDRVPHSRNSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPRDLEVVAATPTSLLISWDAPAVTVRYYRITYGETGGNSPVQEFTVPGSKSTATISGLKPGVDYTITVYAVTGRGDSPASSKPISINYRTEIDKPSQMQVTDVQDNSISVKWLPSSSPVTGYRVTTTPKNGPGPTKTKTAGPDQTEMTIEGLQPTVEYVVSVYAQNPSGESQPLVQTAVTNIDRPKGLAFTDVDVDSIKIAWESPQGQVSRYRVTYSSPEDGIHELFPAPDGEEDTAELQGLRPGSEYTVSVVALHDDMESQPLIGTQSTAIPAPTDLKFTQVTPTSLSAQWTPPNVQLTGYRVRVTPKEKTGPMKEINLAPDSSSVVVSGLMVATKYEVSVYALKDTLTSRPAQGVVTTLENVSPPRRARVTDATETTITISWRTKTETITGFQVDAVPANGQTPIQRTIKPDVRSYTITGLQPGTDYKIYLYTLNDNARSSPVVIDASTAIDAPSNLRFLATTPNSLLVSWQPPRARITGYIIKYEKPGSPPREVVPRPRPGVTEATITGLEPGTEYTIYVIALKNNQKSEPLIGRKKTDELPQLVTLPHPNLHGPEILDVPSTVQKTPFVTHPGYDTGNGIQLPGTSGQQPSVGQQMIFEEHGFRRTTPPTTATPIRHRPRPYPPNVGEEIQIGHIPREDVDYHLYPHGPGLNPNASTGQEALSQTTISWAPFQDTSEYIISCHPVGTDEEPLQFRVPGTSTSATLTGLTRGATYNVIVEALKDQQRHKVREEVVTVGNSVNEGLNQPTDDSCFDPYTVSHYAVGDEWERMSESGFKLLCQCLGFGSGHFRCDSSRWCHDNGVNYKIGEKWDRQGENGQMMSCTCLGNGKGEFKCDPHEATCYDDGKTYHVGEQWQKEYLGAICSCTCFGGQRGWRCDNCRRPGGEPSPEGTTGQSYNQYSQRYHQRTNTNVNCPIECFMPLDVQADREDSRE</Protein_Seq>
    <DNA_Seq>GCCCGCGCCGGCTGTGCTGCACAGGGGGAGGAGAGGGAACCCCAGGCGCGAGCGGGAAGAGGGGACCTGCAGCCACAACTTCTCTGGTCCTCTGCATCCCTTCTGTCCCTCCACCCGTCCCCTTCCCCACCCTCTGGCCCCCACCTTCTTGGAGGCGACAACCCCCGGGAGGCATTAGAAGGGATTTTTCCCGCAGGTTGCGAAGGGAAGCAAACTTGGTGGCAACTTGCCTCCCGGTGCGGGCGTCTCTCCCCCACCGTCTCAACATGCTTAGGGGTCCGGGGCCCGGGCTGCTGCTGCTGGCCGTCCAGTGCCTGGGGACAGCGGTGCCCTCCACGGGAGCCTCGAAGAGCAAGAGGCAGGCTCAGCAAATGGTTCAGCCCCAGTCCCCGGTGGCTGTCAGTCAAAGCAAGCCCGGTTGTTATGACAATGGAAAACACTATCAGATAAATCAACAGTGGGAGCGGACCTACCTAGGCAATGCGTTGGTTTGTACTTGTTATGGAGGAAGCCGAGGTTTTAACTGCGAGAGTAAACCTGAAGCTGAAGAGACTTGCTTTGACAAGTACACTGGGAACACTTACCGAGTGGGTGACACTTATGAGCGTCCTAAAGACTCCATGATCTGGGACTGTACCTGCATCGGGGCTGGGCGAGGGAGAATAAGCTGTACCATCGCAAACCGCTGCCATGAAGGGGGTCAGTCCTACAAGATTGGTGACACCTGGAGGAGACCACATGAGACTGGTGGTTACATGTTAGAGTGTGTGTGTCTTGGTAATGGAAAAGGAGAATGGACCTGCAAGCCCATAGCTGAGAAGTGTTTTGATCATGCTGCTGGGACTTCCTATGTGGTCGGAGAAACGTGGGAGAAGCCCTACCAAGGCTGGATGATGGTAGATTGTACTTGCCTGGGAGAAGGCAGCGGACGCATCACTTGCACTTCTAGAAATAGATGCAACGATCAGGACACAAGGACATCCTATAGAATTGGAGACACCTGGAGCAAGAAGGATAATCGAGGAAACCTGCTCCAGTGCATCTGCACAGGCAACGGCCGAGGAGAGTGGAAGTGTGAGAGGCACACCTCTGTGCAGACCACATCGAGCGGATCTGGCCCCTTCACCGATGTTCGTGCAGCTGTTTACCAACCGCAGCCTCACCCCCAGCCTCCTCCCTATGGCCACTGTGTCACAGACAGTGGTGTGGTCTACTCTGTGGGGATGCAGTGGCTGAAGACACAAGGAAATAAGCAAATGCTTTGCACGTGCCTGGGCAACGGAGTCAGCTGCCAAGAGACAGCTGTAACCCAGACTTACGGTGGCAACTCAAATGGAGAGCCATGTGTCTTACCATTCACCTACAATGGCAGGACGTTCTACTCCTGCACCACAGAAGGGCGACAGGACGGACATCTTTGGTGCAGCACAACTTCGAATTATGAGCAGGACCAGAAATACTCTTTCTGCACAGACCACACTGTTTTGGTTCAGACTCGAGGAGGAAATTCCAATGGTGCCTTGTGCCACTTCCCCTTCCTATACAACAACCACAATTACACTGATTGCACTTCTGAGGGCAGAAGAGACAACATGAAGTGGTGTGGGACCACACAGAACTATGATGCCGACCAGAAGTTTGGGTTCTGCCCCATGGCTGCCCACGAGGAAATCTGCACAACCAATGAAGGGGTCATGTACCGCATTGGAGATCAGTGGGATAAGCAGCATGACATGGGTCACATGATGAGGTGCACGTGTGTTGGGAATGGTCGTGGGGAATGGACATGCATTGCCTACTCGCAGCTTCGAGATCAGTGCATTGTTGATGACATCACTTACAATGTGAACGACACATTCCACAAGCGTCATGAAGAGGGGCACATGCTGAACTGTACATGCTTCGGTCAGGGTCGGGGCAGGTGGAAGTGTGATCCCGTCGACCAATGCCAGGATTCAGAGACTGGGACGTTTTATCAAATTGGAGATTCATGGGAGAAGTATGTGCATGGTGTCAGATACCAGTGCTACTGCTATGGCCGTGGCATTGGGGAGTGGCATTGCCAACCTTTACAGACCTATCCAAGCTCAAGTGGTCCTGTCGAAGTATTTATCACTGAGACTCCGAGTCAGCCCAACTCCCACCCCATCCAGTGGAATGCACCACAGCCATCTCACATTTCCAAGTACATTCTCAGGTGGAGACCTAAAAATTCTGTAGGCCGTTGGAAGGAAGCTACCATACCAGGCCACTTAAACTCCTACACCATCAAAGGCCTGAAGCCTGGTGTGGTATACGAGGGCCAGCTCATCAGCATCCAGCAGTACGGCCACCAAGAAGTGACTCGCTTTGACTTCACCACCACCAGCACCAGCACACCTGTGACCAGCAACACCGTGACAGGAGAGACGACTCCCTTTTCTCCTCTTGTGGCCACTTCTGAATCTGTGACCGAAATCACAGCCAGTAGCTTTGTGGTCTCCTGGGTCTCAGCTTCCGACACCGTGTCGGGATTCCGGGTGGAATATGAGCTGAGTGAGGAGGGAGATGAGCCACAGTACCTGGATCTTCCAAGCACAGCCACTTCTGTGAACATCCCTGACCTGCTTCCTGGCCGAAAATACATTGTAAATGTCTATCAGATATCTGAGGATGGGGAGCAGAGTTTGATCCTGTCTACTTCACAAACAACAGCGCCTGATGCCCCTCCTGACCCGACTGTGGACCAAGTTGATGACACCTCAATTGTTGTTCGCTGGAGCAGACCCCAGGCTCCCATCACAGGGTACAGAATAGTCTATTCGCCATCAGTAGAAGGTAGCAGCACAGAACTCAACCTTCCTGAAACTGCAAACTCCGTCACCCTCAGTGACTTGCAACCTGGTGTTCAGTATAACATCACTATCTATGCTGTGGAAGAAAATCAAGAAAGTACACCTGTTGTCATTCAACAAGAAACCACTGGCACCCCACGCTCAGATACAGTGCCCTCTCCCAGGGACCTGCAGTTTGTGGAAGTGACAGACGTGAAGGTCACCATCATGTGGACACCGCCTGAGAGTGCAGTGACCGGCTACCGTGTGGATGTGATCCCCGTCAACCTGCCTGGCGAGCACGGGCAGAGGCTGCCCATCAGCAGGAACACCTTTGCAGAAGTCACCGGGCTGTCCCCTGGGGTCACCTATTACTTCAAAGTCTTTGCAGTGAGCCATGGGAGGGAGAGCAAGCCTCTGACTGCTCAACAGACAACCAAACTGGATGCTCCCACTAACCTCCAGTTTGTCAATGAAACTGATTCTACTGTCCTGGTGAGATGGACTCCACCTCGGGCCCAGATAACAGGATACCGACTGACCGTGGGCCTTACCCGAAGAGGACAGCCCAGGCAGTACAATGTGGGTCCCTCTGTCTCCAAGTACCCACTGAGGAATCTGCAGCCTGCATCTGAGTACACCGTATCCCTCGTGGCCATAAAGGGCAACCAAGAGAGCCCCAAAGCCACTGGAGTCTTTACCACACTGCAGCCTGGGAGCTCTATTCCACCTTACAACACCGAGGTGACTGAGACCACCATTGTGATCACATGGACGCCTGCTCCAAGAATTGGTTTTAAGCTGGGTGTACGACCAAGCCAGGGAGGAGAGGCACCACGAGAAGTGACTTCAGACTCAGGAAGCATCGTTGTGTCCGGCTTGACTCCAGGAGTAGAATACGTCTACACCATCCAAGTCCTGAGAGATGGACAGGAAAGAGATGCGCCAATTGTAAACAAAGTGGTGACACCATTGTCTCCACCAACAAACTTGCATCTGGAGGCAAACCCTGACACTGGAGTGCTCACAGTCTCCTGGGAGAGGAGCACCACCCCAGACATTACTGGTTATAGAATTACCACAACCCCTACAAACGGCCAGCAGGGAAATTCTTTGGAAGAAGTGGTCCATGCTGATCAGAGCTCCTGCACTTTTGATAACCTGAGTCCCGGCCTGGAGTACAATGTCAGTGTTTACACTGTCAAGGATGACAAGGAAAGTGTCCCTATCTCTGATACCATCATCCCAGCTGTTCCTCCTCCCACTGACCTGCGATTCACCAACATTGGTCCAGACACCATGCGTGTCACCTGGGCTCCACCCCCATCCATTGATTTAACCAACTTCCTGGTGCGTTACTCACCTGTGAAAAATGAGGAAGATGTTGCAGAGTTGTCAATTTCTCCTTCAGACAATGCAGTGGTCTTAACAAATCTCCTGCCTGGTACAGAATATGTAGTGAGTGTCTCCAGTGTCTACGAACAACATGAGAGCACACCTCTTAGAGGAAGACAGAAAACAGGTCTTGATTCCCCAACTGGCATTGACTTTTCTGATATTACTGCCAACTCTTTTACTGTGCACTGGATTGCTCCTCGAGCCACCATCACTGGCTACAGGATCCGCCATCATCCCGAGCACTTCAGTGGGAGACCTCGAGAAGATCGGGTGCCCCACTCTCGGAATTCCATCACCCTCACCAACCTCACTCCAGGCACAGAGTATGTGGTCAGCATCGTTGCTCTTAATGGCAGAGAGGAAAGTCCCTTATTGATTGGCCAACAATCAACAGTTTCTGATGTTCCGAGGGACCTGGAAGTTGTTGCTGCGACCCCCACCAGCCTACTGATCAGCTGGGATGCTCCTGCTGTCACAGTGAGATATTACAGGATCACTTACGGAGAGACAGGAGGAAATAGCCCTGTCCAGGAGTTCACTGTGCCTGGGAGCAAGTCTACAGCTACCATCAGCGGCCTTAAACCTGGAGTTGATTATACCATCACTGTGTATGCTGTCACTGGCCGTGGAGACAGCCCCGCAAGCAGCAAGCCAATTTCCATTAATTACCGAACAGAAATTGACAAACCATCCCAGATGCAAGTGACCGATGTTCAGGACAACAGCATTAGTGTCAAGTGGCTGCCTTCAAGTTCCCCTGTTACTGGTTACAGAGTAACCACCACTCCCAAAAATGGACCAGGACCAACAAAAACTAAAACTGCAGGTCCAGATCAAACAGAAATGACTATTGAAGGCTTGCAGCCCACAGTGGAGTATGTGGTTAGTGTCTATGCTCAGAATCCAAGCGGAGAGAGTCAGCCTCTGGTTCAGACTGCAGTAACCAACATTGATCGCCCTAAAGGACTGGCATTCACTGATGTGGATGTCGATTCCATCAAAATTGCTTGGGAAAGCCCACAGGGGCAAGTTTCCAGGTACAGGGTGACCTACTCGAGCCCTGAGGATGGAATCCATGAGCTATTCCCTGCACCTGATGGTGAAGAAGACACTGCAGAGCTGCAAGGCCTCAGACCGGGTTCTGAGTACACAGTCAGTGTGGTTGCCTTGCACGATGATATGGAGAGCCAGCCCCTGATTGGAACCCAGTCCACAGCTATTCCTGCACCAACTGACCTGAAGTTCACTCAGGTCACACCCACAAGCCTGAGCGCCCAGTGGACACCACCCAATGTTCAGCTCACTGGATATCGAGTGCGGGTGACCCCCAAGGAGAAGACCGGACCAATGAAAGAAATCAACCTTGCTCCTGACAGCTCATCCGTGGTTGTATCAGGACTTATGGTGGCCACCAAATATGAAGTGAGTGTCTATGCTCTTAAGGACACTTTGACAAGCAGACCAGCTCAGGGAGTTGTCACCACTCTGGAGAATGTCAGCCCACCAAGAAGGGCTCGTGTGACAGATGCTACTGAGACCACCATCACCATTAGCTGGAGAACCAAGACTGAGACGATCACTGGCTTCCAAGTTGATGCCGTTCCAGCCAATGGCCAGACTCCAATCCAGAGAACCATCAAGCCAGATGTCAGAAGCTACACCATCACAGGTTTACAACCAGGCACTGACTACAAGATCTACCTGTACACCTTGAATGACAATGCTCGGAGCTCCCCTGTGGTCATCGACGCCTCCACTGCCATTGATGCACCATCCAACCTGCGTTTCCTGGCCACCACACCCAATTCCTTGCTGGTATCATGGCAGCCGCCACGTGCCAGGATTACCGGCTACATCATCAAGTATGAGAAGCCTGGGTCTCCTCCCAGAGAAGTGGTCCCTCGGCCCCGCCCTGGTGTCACAGAGGCTACTATTACTGGCCTGGAACCGGGAACCGAATATACAATTTATGTCATTGCCCTGAAGAATAATCAGAAGAGCGAGCCCCTGATTGGAAGGAAAAAGACAGACGAGCTTCCCCAACTGGTAACCCTTCCACACCCCAATCTTCATGGACCAGAGATCTTGGATGTTCCTTCCACAGTTCAAAAGACCCCTTTCGTCACCCACCCTGGGTATGACACTGGAAATGGTATTCAGCTTCCTGGCACTTCTGGTCAGCAACCCAGTGTTGGGCAACAAATGATCTTTGAGGAACATGGTTTTAGGCGGACCACACCGCCCACAACGGCCACCCCCATAAGGCATAGGCCAAGACCATACCCGCCGAATGTAGGACAAGAAGCTCTCTCTCAGACAACCATCTCATGGGCCCCATTCCAGGACACTTCTGAGTACATCATTTCATGTCATCCTGTTGGCACTGATGAAGAACCCTTACAGTTCAGGGTTCCTGGAACTTCTACCAGTGCCACTCTGACAGGCCTCACCAGAGGTGCCACCTACAACATCATAGTGGAGGCACTGAAAGACCAGCAGAGGCATAAGGTTCGGGAAGAGGTTGTTACCGTGGGCAACTCTGTCAACGAAGGCTTGAACCAACCTACGGATGACTCGTGCTTTGACCCCTACACAGTTTCCCATTATGCCGTTGGAGATGAGTGGGAACGAATGTCTGAATCAGGCTTTAAACTGTTGTGCCAGTGCTTAGGCTTTGGAAGTGGTCATTTCAGATGTGATTCATCTAGATGGTGCCATGACAATGGTGTGAACTACAAGATTGGAGAGAAGTGGGACCGTCAGGGAGAAAATGGCCAGATGATGAGCTGCACATGTCTTGGGAACGGAAAAGGAGAATTCAAGTGTGACCCTCATGAGGCAACGTGTTATGATGATGGGAAGACATACCACGTAGGAGAACAGTGGCAGAAGGAATATCTCGGTGCCATTTGCTCCTGCACATGCTTTGGAGGCCAGCGGGGCTGGCGCTGTGACAACTGCCGCAGACCTGGGGGTGAACCCAGTCCCGAAGGCACTACTGGCCAGTCCTACAACCAGTATTCTCAGAGATACCATCAGAGAACAAACACTAATGTTAATTGCCCAATTGAGTGCTTCATGCCTTTAGATGTACAGGCTGACAGAGAAGATTCCCGAGAGTAAATCATCTTTCCAATCCAGAGGAACAAGCATGTCTCTCTGCCAAGATCCATCTAAACTGGAGTGATGTTAGCAGACCCAGCTTAGAGTTCTTCTTTCTTTCTTAAGCCCTTTGCTCTGGAGGAAGTTCTCCAGCTTCAGCTCAACTCACAGCTTCTCCAAGCATCACCCTGGGAGTTTCCTGAGGGTTTTCTCATAAATGAGGGCTGCACATTGCCTGTTCTGCTTCGAAGTATTCAATACCGCTCAGTATTTTAAATGAAGTGATTCTAAGATTTGGTTTGGGATCAATAGGAAAGCATATGCAGCCAACCAAGATGCAAATGTTTTGAAATGATATGACCAAAATTTTAAGTAGGAAAGTCACCCAAACACTTCTGCTTTCACTTAAGTGTCTGGCCCGCAATACTGTAGGAACAAGCATGATCTTGTTACTGTGATATTTTAAATATCCACAGTACTCACTTTTTCCAAATGATCCTAGTAATTGCCTAGAAATATCTTTCTCTTACCTGTTATTTATCAATTTTTCCCAGTATTTTTATACGGAAAAAATTGTATTGAAAACACTTAGTATGCAGTTGATAAGAGGAATTTGGTATAATTATGGTGGGTGATTATTTTTTATACTGTATGTGCCAAAGCTTTACTACTGTGGAAAGACAACTGTTTTAATAAAAGATTTACATTCCACAACTTGAAGTTCATCTATTTGATATAAGACACCTTCGGGGGAAATAATTCCTGTGAATATTCTTTTTCAATTCAGCAAACATTTGAAAATCTATGATGTGCAAGTCTAATTGTTGATTTCAGTACAAGATTTTCTAAATCAGTTGCTACAAAAACTGATTGGTTTTTGTCACTTCATCTCTTCACTAATGGAGATAGCTTTACACTTTCTGCTTTAATAGATTTAAGTGGACCCCAATATTTATTAAAATTGCTAGTTTACCGTTCAGAAGTATAATAGAAATAATCTTTAGTTGCTCTTTTCTAACCATTGTAATTCTTCCCTTCTTCCCTCCACCTTTCCTTCATTGAATAAACCTCTGTTCAAAGAGATTGCCTGCAAGGGAAATAAAAATGACTAAGATATTAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Hepatocytes</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Fibroblasts</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Epithelial and other cell types</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Secreted</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Proteinaceous extracellular matrix</CellLocal>
      <Ontology_ID>GO:0005578</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>ER-Golgi intermediate compartment</CellLocal>
      <Ontology_ID>GO:0005793</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular region</CellLocal>
      <Ontology_ID>GO:0005576</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Fibrinogen complex</CellLocal>
      <Ontology_ID>GO:0005577</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Platelet alpha granule lumen</CellLocal>
      <Ontology_ID>GO:0031093</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>FN1</Gene_Name>
    <Gene_Alias>FN</Gene_Alias>
    <Gene_ID>2335</Gene_ID>
    <Genbank_ACCN>NM_002026</Genbank_ACCN>
    <Protein_ACCN>NP_002017</Protein_ACCN>
    <HGNC_ID>3778</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/2335</Gene_URL>
    <UCSC_ID>uc002vfj.3</UCSC_ID>
    <EMBL_ID>ENSG00000115414</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Calciphylaxis</Disease_Name>
      <Disease_Detail>Calciphylaxis</Disease_Detail>
      <Disease_DB>CLC001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/calciphylaxis?search=FN1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Vitreous Detachment</Disease_Name>
      <Disease_Detail>Vitreous Detachment</Disease_Detail>
      <Disease_DB>VTR003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/vitreous_detachment?search=FN1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Secretory Meningioma</Disease_Name>
      <Disease_Detail>Secretory Meningioma</Disease_Detail>
      <Disease_DB>SCR001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/secretory_meningioma?search=FN1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Arterial Tortuosity Syndrome</Disease_Name>
      <Disease_Detail>Arterial Tortuosity Syndrome</Disease_Detail>
      <Disease_DB>ART001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/arterial_tortuosity_syndrome?search=FN1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colorectal Cancer</Disease_Name>
      <Disease_Detail>Colorectal Cancer</Disease_Detail>
      <Disease_DB>CLR023</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colorectal_cancer?search=FN1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Weber Syndrome</Disease_Name>
      <Disease_Detail>Weber Syndrome</Disease_Detail>
      <Disease_DB>WBR001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/weber_syndrome?search=FN1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ureteral Disease</Disease_Name>
      <Disease_Detail>Ureteral Disease</Disease_Detail>
      <Disease_DB>URT031</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ureteral_disease?search=FN1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Glomerulopathy with Fibronectin Deposits 2</Disease_Name>
      <Disease_Detail>Glomerulopathy with Fibronectin Deposits 2</Disease_Detail>
      <Disease_DB>GLM015</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/glomerulopathy_with_fibronectin_deposits_2?search=FN1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cryofibrinogenemia</Disease_Name>
      <Disease_Detail>Cryofibrinogenemia</Disease_Detail>
      <Disease_DB>CRY006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cryofibrinogenemia?search=FN1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Type Ii Mixed Cryoglobulinemia</Disease_Name>
      <Disease_Detail>Type Ii Mixed Cryoglobulinemia</Disease_Detail>
      <Disease_DB>TYP024</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/type_ii_mixed_cryoglobulinemia?search=FN1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Myeloma</Disease_Name>
      <Disease_Detail>Myeloma</Disease_Detail>
      <Disease_DB>MYL007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/myeloma?search=FN1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Secondary Syphilis</Disease_Name>
      <Disease_Detail>Secondary Syphilis</Disease_Detail>
      <Disease_DB>SCN006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/secondary_syphilis?search=FN1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sturge-Weber Syndrome</Disease_Name>
      <Disease_Detail>Sturge-Weber Syndrome</Disease_Detail>
      <Disease_DB>STR039</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sturge_weber_syndrome?search=FN1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Mycobacterium Kansasii</Disease_Name>
      <Disease_Detail>Mycobacterium Kansasii</Disease_Detail>
      <Disease_DB>MYC017</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/mycobacterium_kansasii?search=FN1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Plasma Fibronectin Deficiency</Disease_Name>
      <Disease_Detail>Plasma Fibronectin Deficiency</Disease_Detail>
      <Disease_DB>PLS026</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/plasma_fibronectin_deficiency?search=FN1#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal Structure of the Fibronectin 8-9FnI Domain Pair in Complex with a Type-I Collagen Peptide</PDB_Title>
      <PDB_ID>3EJH</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3EJH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Identification and structural analysis of type I collagen sites in complex with fibronectin fragments.</PubMed_Title>
      <Author>Erat, M.C., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2009)106:4195-4200</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19251642?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SOLUTION STRUCTURE OF THE COMPLEX OF 1F12F1 FROM FIBRONECTIN WITH B3 FROM FNBB FROM S. DYSGALACTIAE</PDB_Title>
      <PDB_ID>1O9A</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1O9A</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Pathogenic Bacteria Attach to Human Fibronectin Through a Tandem Beta-Zipper</PubMed_Title>
      <Author>Schwarz-Linek, U., et al.</Author>
      <Journal>Nature(2003)423:177</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12736686?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF THE TENTH TYPE III CELL ADHESION MODULE OF HUMAN FIBRONECTIN</PDB_Title>
      <PDB_ID>1FNA</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FNA</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the tenth type III cell adhesion module of human fibronectin.</PubMed_Title>
      <Author>Dickinson, C.D., et al.</Author>
      <Journal>J.Mol.Biol.(1994)236:1079-1092</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8120888?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>FOURTH AND FIFTH FIBRONECTIN TYPE I MODULE PAIR</PDB_Title>
      <PDB_ID>1FBR</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FBR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure of a pair of fibronectin type 1 modules with fibrin binding activity.</PubMed_Title>
      <Author>Williams, M.J., et al.</Author>
      <Journal>J.Mol.Biol.(1994)235:1302-1311</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8308892?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Complex of a Low Affinity Collagen Site with the Fibronectin 8-9FnI Domain Pair</PDB_Title>
      <PDB_ID>3GXE</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3GXE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Determinants of high affinity for the fibronectin-collagen interaction</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>SECOND AND THIRD FIBRONECTIN TYPE I MODULE PAIR (CRYSTAL FORM II).</PDB_Title>
      <PDB_ID>2CG7</PDB_ID>
      <Resolution>1.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2CG7</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Solution and Crystal Structures of a Module Pair from the Staphylococcus Aureus-Binding Site of Human Fibronectin-A Tale with a Twist.</PubMed_Title>
      <Author>Rudino-Pinera, E., et al.</Author>
      <Journal>J.Mol.Biol.(2007)368:833</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17368672?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HEPARIN AND INTEGRIN BINDING SEGMENT OF HUMAN FIBRONECTIN</PDB_Title>
      <PDB_ID>1FNH</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FNH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of a heparin- and integrin-binding segment of human fibronectin.</PubMed_Title>
      <Author>Sharma, A., et al.</Author>
      <Journal>EMBO J.(1999)18:1468-1479</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10075919?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SECOND AND THIRD FIBRONECTIN TYPE I MODULE PAIR (CRYSTAL FORM I).</PDB_Title>
      <PDB_ID>2CG6</PDB_ID>
      <Resolution>1.55</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2CG6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Solution and Crystal Structures of a Module Pair from the Staphylococcus Aureus-Binding Site of Human Fibronectin-A Tale with a Twist.</PubMed_Title>
      <Author>Rudino-Pinera, E., et al.</Author>
      <Journal>J.Mol.Biol.(2007)368:833</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17368672?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF CORE-SWAPPED MUTANT OF FIBRONECTIN</PDB_Title>
      <PDB_ID>2CK2</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2CK2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Designing an Extracellular Matrix Protein with Enhanced Mechanical Stability</PubMed_Title>
      <Author>Ng, S.P., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2007)104:9633</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17535921?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Anastellin</PDB_Title>
      <PDB_ID>1Q38</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Q38</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Anastellin, an FN3 fragment with fibronectin polymerization activity, resembles amyloid fibril precursors</PubMed_Title>
      <Author>Briknarova, K., et al.</Author>
      <Journal>J.Mol.Biol.(2003)332:205-215</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12946358?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>FRAGMENT OF HUMAN FIBRONECTIN ENCOMPASSING TYPE-III REPEATS 7 THROUGH 10</PDB_Title>
      <PDB_ID>1FNF</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FNF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>2.0 A crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region.</PubMed_Title>
      <Author>Leahy, D.J., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(1996)84:155-164</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8548820?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>NMR STRUCTURE OF THE FIBRONECTIN EDA DOMAIN, NMR, 20 STRUCTURES</PDB_Title>
      <PDB_ID>1J8K</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1J8K</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>NMR structure of human fibronectin EDA.</PubMed_Title>
      <Author>Niimi, T., et al.</Author>
      <Journal>J.Biomol.NMR(2001)21:281-284</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11775745?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Fibronectin fragment</PDB_Title>
      <PDB_ID>3M7P</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3M7P</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Zinc Induces Structural Reorganization of Gelatin Binding Domain from Human Fibronectin and Affects Collagen Binding</PubMed_Title>
      <Author>Graille, M., et al.</Author>
      <Journal>Structure(2010)18:710-718</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20541508?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human estrogen receptor alpha ligand-binding domain in complex with estradiol and the E2#23 FN3 monobody</PDB_Title>
      <PDB_ID>2OCF</PDB_ID>
      <Resolution>2.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2OCF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Probing protein conformational changes in living cells by using designer binding proteins: application to the estrogen receptor.</PubMed_Title>
      <Author>Koide, A., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2002)99:1253-1258</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11818562?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SOLUTION NMR STRUCTURE OF THE GLYCOSYLATED SECOND TYPE TWO MODULE OF FIBRONECTIN, 20 STRUCTURES</PDB_Title>
      <PDB_ID>2FN2</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2FN2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure of the glycosylated second type 2 module of fibronectin.</PubMed_Title>
      <Author>Sticht, H., et al.</Author>
      <Journal>J.Mol.Biol.(1998)276:177-187</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9514732?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Solution structure of the second type III domain of human Fibronectin: ensemble of 25 structures</PDB_Title>
      <PDB_ID>2H45</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2H45</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Interdomain association in fibronectin: insight into cryptic sites and fibrillogenesis.</PubMed_Title>
      <Author>Vakonakis, I., et al.</Author>
      <Journal>Embo J.(2007)26:2575-2583</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17464288?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Solution structure of the 11th FN1 domain from human Fibronectin 1</PDB_Title>
      <PDB_ID>2EC3</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2EC3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure of the 11th FN1 domain from human Fibronectin 1</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>SOLUTION STRUCTURE OF 6F11F22F2, A COMPACT THREE-MODULE FRAGMENT OF THE GELATIN-BINDING DOMAIN OF HUMAN FIBRONECTIN</PDB_Title>
      <PDB_ID>1E8B</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1E8B</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Hairpin Structure of the (6)F1(1)F2(2)F2 Fragment from Human Fibronectin Enhances Gelatin Binding</PubMed_Title>
      <Author>Pickford, A.R., et al.</Author>
      <Journal>Embo J.(2001)20:1519</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11285216?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Complex of the first and second type III domains of human Fibronectin in solution</PDB_Title>
      <PDB_ID>2HA1</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2HA1</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Interdomain association in fibronectin: insight into cryptic sites and fibrillogenesis.</PubMed_Title>
      <Author>Vakonakis, I., et al.</Author>
      <Journal>Embo J.(2007)26:2575-2583</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17464288?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE THREE-DIMENSIONAL STRUCTURE OF THE TENTH TYPE III MODULE OF FIBRONECTIN: AN INSIGHT INTO RGD-MEDIATED INTERACTIONS</PDB_Title>
      <PDB_ID>1TTF</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1TTF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The three-dimensional structure of the tenth type III module of fibronectin: an insight into RGD-mediated interactions.</PubMed_Title>
      <Author>Main, A.L., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(1992)71:671-678</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/1423622?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SOLUTION STRUCTURE OF 2F13F1 FROM HUMAN FIBRONECTIN</PDB_Title>
      <PDB_ID>2CKU</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2CKU</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Solution and Crystal Structures of a Module Pair from the Staphylococcus Aureus-Binding Site of Human Fibronectin-A Tale with a Twist.</PubMed_Title>
      <Author>Rudino-Pinera, E., et al.</Author>
      <Journal>J.Mol.Biol.(2007)368:833</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17368672?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the second and third fibronectin f1 modules in complex with a fragment of staphylococcus aureus fnbpa-1</PDB_Title>
      <PDB_ID>2RKZ</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2RKZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structures of fibronectin-binding sites from Staphylococcus aureus FnBPA in complex with fibronectin domains</PubMed_Title>
      <Author>Bingham, R.J., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.Usa(2008)105:12254-12258</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18713862?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Solution structure of the second type III domain of human Fibronectin: minimized average structure</PDB_Title>
      <PDB_ID>2H41</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2H41</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Interdomain association in fibronectin: insight into cryptic sites and fibrillogenesis.</PubMed_Title>
      <Author>Vakonakis, I., et al.</Author>
      <Journal>Embo J.(2007)26:2575-2583</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17464288?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the fourth and fifth fibronectin F1 modules in complex with a fragment of staphylococcus aureus fnbpa-5</PDB_Title>
      <PDB_ID>2RL0</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2RL0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structures of fibronectin-binding sites from Staphylococcus aureus FnBPA in complex with fibronectin domains</PubMed_Title>
      <Author>Bingham, R.J., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.Usa(2008)105:12254-12258</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18713862?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE THREE-DIMENSIONAL STRUCTURE OF THE TENTH TYPE III MODULE OF FIBRONECTIN: AN INSIGHT INTO RGD-MEDIATED INTERACTIONS</PDB_Title>
      <PDB_ID>1TTG</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1TTG</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The three-dimensional structure of the tenth type III module of fibronectin: an insight into RGD-mediated interactions.</PubMed_Title>
      <Author>Main, A.L., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(1992)71:671-678</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/1423622?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SOLUTION STRUCTURE OF 6F11F22F2, A COMPACT THREE-MODULE FRAGMENT OF THE GELATIN-BINDING DOMAIN OF HUMAN FIBRONECTIN</PDB_Title>
      <PDB_ID>1E88</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1E88</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Hairpin Structure of the (6)F1(1)F2(2)F2 Fragment from Human Fibronectin Enhances Gelatin Binding</PubMed_Title>
      <Author>Pickford, A.R., et al.</Author>
      <Journal>Embo J.(2001)20:1519</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11285216?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Solution structure of the first type III module of human fibronectin determined by 1H, 15N NMR spectroscopy</PDB_Title>
      <PDB_ID>1OWW</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1OWW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure and functional significance of mechanically unfolded fibronectin type III1 intermediates</PubMed_Title>
      <Author>Gao, M., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2003)100:14784-14789</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/14657397?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Human Type III Fibronectin Extradomain B and Domain 8</PDB_Title>
      <PDB_ID>2GEE</PDB_ID>
      <Resolution>2.01</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2GEE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural insights into fibronectin type III domain-mediated signaling.</PubMed_Title>
      <Author>Bencharit, S., et al.</Author>
      <Journal>J.Mol.Biol.(2007)367:303-309</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17261313?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the fourth and fifth fibronectin F1 modules in complex with a fragment of staphylococcus aureus fnbpa-1</PDB_Title>
      <PDB_ID>2RKY</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2RKY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structures of fibronectin-binding sites from Staphylococcus aureus FnBPA in complex with fibronectin domains</PubMed_Title>
      <Author>Bingham, R.J., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.Usa(2008)105:12254-12258</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18713862?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>NMR STRUCTURE OF THE FIBRONECTIN ED-B DOMAIN, NMR, 20 STRUCTURES</PDB_Title>
      <PDB_ID>2FNB</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2FNB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>NMR structure of the human oncofoetal fibronectin ED-B domain, a specific marker for angiogenesis.</PubMed_Title>
      <Author>Fattorusso, R., et al.</Author>
      <Journal>Structure Fold.Des.(1999)7:381-390</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10196121?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SOLUTION STRUCTURE OF A PAIR OF MODULES FROM THE GELATIN-BINDING DOMAIN OF FIBRONECTIN</PDB_Title>
      <PDB_ID>1QO6</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1QO6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution Structure of a Pair of Modules from the Gelatin-Binding Domain of Fibronectin</PubMed_Title>
      <Author>Bocquier, A.A., et al.</Author>
      <Journal>Structure(1999)7:1451</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10647176?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF THE SECOND AND THIRD FIBRONECTIN F1 MODULES IN COMPLEX WITH A FRAGMENT OF STREPTOCOCCUS PYOGENES SFBI-5</PDB_Title>
      <PDB_ID>3ZRZ</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3ZRZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural and Functional Analysis of the Tandem Beta-Zipper Interaction of a Streptococcal Protein with Human Fibronectin.</PubMed_Title>
      <Author>Norris, N.C., et al.</Author>
      <Journal>J.Biol.Chem.(2011)286:38311</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21840989?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the second and third fibronectin F1 modules in complex with a fragment of staphylococcus aureus fnbpa-5</PDB_Title>
      <PDB_ID>3CAL</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CAL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structures of fibronectin-binding sites from Staphylococcus aureus FnBPA in complex with fibronectin domains</PubMed_Title>
      <Author>Bingham, R.J., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.Usa(2008)105:12254-12258</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18713862?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SOLUTION STRUCTURE OF THE N-TERMINAL F1 MODULE PAIR FROM HUMAN FIBRONECTIN</PDB_Title>
      <PDB_ID>1QGB</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1QGB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure of the N-terminal F1 module pair from human fibronectin.</PubMed_Title>
      <Author>Potts, J.R., et al.</Author>
      <Journal>Biochemistry(1999)38:8304-8312</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10387076?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04512</Pathway_ID>
      <Pathway_Title>ECM-receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04512</Pathway_ID>
      <Pathway_Title>ECM-receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04512</Pathway_ID>
      <Pathway_Title>ECM-receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05200</Pathway_ID>
      <Pathway_Title>Pathways in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05205</Pathway_ID>
      <Pathway_Title>Proteoglycans in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04810</Pathway_ID>
      <Pathway_Title>Regulation of actin cytoskeleton</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cell motility</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04512</Pathway_ID>
      <Pathway_Title>ECM-receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05100</Pathway_ID>
      <Pathway_Title>Bacterial invasion of epithelial cells</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04512</Pathway_ID>
      <Pathway_Title>ECM-receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05205</Pathway_ID>
      <Pathway_Title>Proteoglycans in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04512</Pathway_ID>
      <Pathway_Title>ECM-receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04512</Pathway_ID>
      <Pathway_Title>ECM-receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04512</Pathway_ID>
      <Pathway_Title>ECM-receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05205</Pathway_ID>
      <Pathway_Title>Proteoglycans in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04512</Pathway_ID>
      <Pathway_Title>ECM-receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04512</Pathway_ID>
      <Pathway_Title>ECM-receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04512</Pathway_ID>
      <Pathway_Title>ECM-receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04512</Pathway_ID>
      <Pathway_Title>ECM-receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05222</Pathway_ID>
      <Pathway_Title>Small cell lung cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>All beta proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.c.b.d.b.d.html</SCOP_URL>
    <CATH_Class>Class 2: Mainly Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1fna</CATH_URL>
  </Fold>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>